MCPRX
Price
$23.92
Change
-$0.19 (-0.79%)
Updated
Jun 26 closing price
Net Assets
13.73B
PAMCX
Price
$93.52
Change
+$0.36 (+0.39%)
Updated
Jun 26 closing price
Net Assets
22.62B
Interact to see
Advertisement

MCPRX vs PAMCX

MCPRX vs PAMCX Comparison Chart in %
View a ticker or compare two or three
VS
MCPRX vs. PAMCX commentary
Jun 29, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCPRX is a StrongBuy and PAMCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PAMCX has more cash in the bank: 22.6B vs. MCPRX (13.7B). MCPRX (0.00) and PAMCX (0.00) have matching dividends . MCPRX was incepted earlier than PAMCX: MCPRX (23 years) vs PAMCX (26 years). MCPRX (1.28) is less costly to investors than PAMCX (1.02). MCPRX is a more actively managed with annual turnover of: 54.00 vs. PAMCX (31.50). MCPRX has a lower initial minimum investment than PAMCX: MCPRX (0) vs PAMCX (2500). PAMCX annual gain was more profitable for investors over the last year : -0.82 vs. MCPRX (-14.08). MCPRX return over 5 years is better than : -13.65 vs. PAMCX (-21.74).
MCPRXPAMCXMCPRX / PAMCX
Total Expense Ratio1.271.02125%
Annual Report Gross Expense Ratio1.281.02125%
Fund Existence23 years26 years-
Gain YTD5.1892.747189%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets13.7B22.6B61%
Annual Yield % from dividends0.000.00-
Returns for 1 year-14.08-0.821,724%
Returns for 3 years5.47-0.14-3,938%
Returns for 5 years-13.65-21.7463%
Returns for 10 years82.0433.33246%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IVGTX9.790.14
+1.45%
VY® Morgan Stanley Global Franchise S
CRRRX16.830.16
+0.96%
Columbia Sm Cp Val and Inflection Inst2
PEOPX66.08-0.03
-0.05%
BNY Mellon S&P 500 Index
SEEHX32.36-0.02
-0.06%
Steward Values Enhanced Lg Cap R6
FMCKX49.16-0.87
-1.74%
Fidelity Advisor Focused Em Mkts C